274 related articles for article (PubMed ID: 8637999)
1. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Shulkin BL; Hutchinson RJ; Castle VP; Yanik GA; Shapiro B; Sisson JC
Radiology; 1996 Jun; 199(3):743-50. PubMed ID: 8637999
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
Shulkin BL; Thompson NW; Shapiro B; Francis IR; Sisson JC
Radiology; 1999 Jul; 212(1):35-41. PubMed ID: 10405717
[TBL] [Abstract][Full Text] [Related]
3. PET hydroxyephedrine imaging of neuroblastoma.
Shulkin BL; Wieland DM; Baro ME; Ungar DR; Mitchell DS; Dole MG; Rawwas JB; Castle VP; Sisson JC; Hutchinson RJ
J Nucl Med; 1996 Jan; 37(1):16-21. PubMed ID: 8543986
[TBL] [Abstract][Full Text] [Related]
4. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
[TBL] [Abstract][Full Text] [Related]
5. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
7. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
Taggart DR; Han MM; Quach A; Groshen S; Ye W; Villablanca JG; Jackson HA; Mari Aparici C; Carlson D; Maris J; Hawkins R; Matthay KK
J Clin Oncol; 2009 Nov; 27(32):5343-9. PubMed ID: 19805691
[TBL] [Abstract][Full Text] [Related]
8. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.
Shulkin BL; Koeppe RA; Francis IR; Deeb GM; Lloyd RV; Thompson NW
Radiology; 1993 Mar; 186(3):711-5. PubMed ID: 8430179
[TBL] [Abstract][Full Text] [Related]
10. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Sharp SE; Shulkin BL; Gelfand MJ; Salisbury S; Furman WL
J Nucl Med; 2009 Aug; 50(8):1237-43. PubMed ID: 19617326
[TBL] [Abstract][Full Text] [Related]
11. FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET.
Macfarlane DJ; Shulkin BL; Murphy K; Wolf GT
Eur J Nucl Med; 1995 Nov; 22(11):1347-50. PubMed ID: 8575489
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
[TBL] [Abstract][Full Text] [Related]
13. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
Melzer HI; Coppenrath E; Schmid I; Albert MH; von Schweinitz D; Tudball C; Bartenstein P; Pfluger T
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1648-58. PubMed ID: 21617976
[TBL] [Abstract][Full Text] [Related]
14. Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET.
Menzel C; Graichen S; Berner U; Risse JH; Diehl M; Döbert N; Hamscho N; Grünwald F
Acta Med Austriaca; 2003; 30(2):37-40. PubMed ID: 12752086
[TBL] [Abstract][Full Text] [Related]
15. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
[TBL] [Abstract][Full Text] [Related]
16. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
Lapela M; Grénman R; Kurki T; Joensuu H; Leskinen S; Lindholm P; Haaparanta M; Ruotsalainen U; Minn H
Radiology; 1995 Oct; 197(1):205-11. PubMed ID: 7568825
[TBL] [Abstract][Full Text] [Related]
17. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Nguyen NC; Bhatla D; Osman MM
J Nucl Med; 2010 Feb; 51(2):330-1; author reply 331. PubMed ID: 20080890
[No Abstract] [Full Text] [Related]
18. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.
Bouvier JF; Philip T; Chauvot P; Brunat Mentigny M; Ducrettet F; Maïassi N; Lahneche BE
Prog Clin Biol Res; 1988; 271():707-20. PubMed ID: 3261425
[TBL] [Abstract][Full Text] [Related]
20. Comparison of MIBG and pentetreotide scintigraphy in children with neuroblastoma. Is the expression of somatostatin receptors a prognostic factor?
Kropp J; Hofmann M; Bihl H
Anticancer Res; 1997; 17(3B):1583-8. PubMed ID: 9179198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]